IonitaCMAcasaiG. Management of juvenile myasthenia gravis. Pediatr Neurol. 2013;48:95-104.
2.
AndrewsPIMasseyJMHowardJFJrSandersDB. Race, sex, and puberty influence onset, severity, and outcome in juvenile myasthenia gravis. Neurology. 1994;44:1208-1214.
3.
LiewWKKangPB. Update on juvenile myasthenia gravis. Curr Opin Pediatr. 2013;25:694-700.
4.
SiebJP. Myasthenia gravis: an update for the clinician. Clin Exp Immunol. 2014;175:408-418.
5.
MullaneyPVajasarJSmithRBunicicJR. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children. Ophthalmology. 2000;107:504-510.
6.
GrobDBrunnerNNambaTPagalaM. Lifetime course of myasthenia gravis. Muscle Nerve. 2008;37:141-149.
7.
PittM. Neurophysiological strategies for the diagnosis of disorders of the neuromuscular junction in children. Dev Med Child Neurol. 2008;50:328-333.
8.
PaduaLCaliandroPDi IasiGPazzagliaCCiaraffaFEvoliA. Reliability of SFEMG in diagnosing myasthenia gravis: sensitivity and specificity calculated on 100 prospective cases. Clin Neurophysiol. 2014;125:1270-1273.